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Introduction {#sec1}
============

Glutamate receptors of the AMPA subtype (AMPARs) mediate fast excitatory signaling throughout the mammalian brain ([@bib70]). Typically, postsynaptic AMPARs are exposed to very brief glutamate transients that are thought to reach millimolar concentrations ([@bib6], [@bib11]), but at some synapses the intersynaptic diffusion of neurotransmitter results in receptors experiencing slower glutamate waveforms with peak concentrations in the micromolar range ([@bib3], [@bib43], [@bib71]). How the receptors respond to these different spatiotemporal glutamate concentration profiles shapes synaptic signaling ([@bib27], [@bib43]). The functional and pharmacological properties of AMPARs reflect the nature of their pore-forming subunits (GluA1--4) ([@bib5], [@bib22], [@bib30], [@bib34], [@bib45]) and that of their associated auxiliary proteins, including transmembrane AMPAR regulatory proteins (TARPs) ([@bib69]), cornichons ([@bib53]), cystine knot proteins ([@bib74]), and GSG1L ([@bib54], [@bib57]). Notably, TARP γ-2 (stargazin) enhances agonist potency and efficacy, increases channel conductance, slows deactivation and desensitization, and reduces the voltage-dependent block of Ca^2+^-permeable (GluA2-lacking) AMPARs by intracellular polyamines ([@bib10], [@bib39], [@bib47], [@bib61], [@bib69]).

Each subunit of the AMPAR tetramer has a modular structure with an amino terminal domain, a ligand binding domain (LBD), a pore-forming transmembrane domain, and an intracellular C-terminal domain ([@bib37], [@bib60]). Assembled receptors interact with up to four TARPs ([@bib23], [@bib31], [@bib58]), primarily through transmembrane contacts running the length of the pore-forming regions as well as through contacts with the ligand binding domain ([@bib56], [@bib73], [@bib78]). AMPAR interactions with the TARP intracellular C-terminal domain, its first extracellular loop (Ex1), and the transmembrane (TM) regions can all modulate multiple receptor properties ([@bib4], [@bib7], [@bib14], [@bib63], [@bib69], [@bib72]). The clamshell-like LBDs are arranged as a dimer of dimers. Each LBD is able to bind a single glutamate molecule ([@bib1], [@bib51]), which stabilizes a more closed state of the clamshell ([@bib33], [@bib49], [@bib76]), producing tension in linkers connected to the pore ([@bib29]). When successive LBDs are closed, the pore generates subconductance levels of increasing amplitude, up to a main conductance when the receptor is fully liganded ([@bib21], [@bib51], [@bib59]). In the continued presence of glutamate, the receptors desensitize because of rupture of the interface between LBD dimers, which relieves tension on the pore linkers and allows the channel to close ([@bib2], [@bib38], [@bib64]). Desensitization can be triggered by just a single LBD closure ([@bib50]). Interaction between the AMPAR LBD and the Ex1 loop of the TARP is thought to stabilize the channel open state and, thus, slow desensitization ([@bib4], [@bib14], [@bib36], [@bib73], [@bib78]).

Despite the multiple regions of contact between AMPAR and TARP, it has been suggested that desensitization leads to a "functional uncoupling" of the TARP ([@bib40], [@bib55]) or even the complete dissociation of TARP and AMPAR ([@bib40]). This proposal arose initially from the observation that the steady-state concentration-response relationship for GluA1 expressed with TARP γ-2 was biphasic, with a decline in current at high glutamate concentrations, a phenomenon termed "autoinactivation" ([@bib40], [@bib55]). The physical separation of AMPARs and TARPs has been questioned ([@bib55], [@bib56], [@bib67]). However, it has been proposed that desensitization-induced dissociation of AMPARs from synaptically anchored TARPs can modulate short-term synaptic plasticity by allowing the liberated receptors to diffuse from the post-synaptic domain and, thus, be rapidly replaced ([@bib13], [@bib25], [@bib40]). Such a mechanism would have important implications for high-frequency central transmission, given the importance of AMPAR lateral mobility in maintaining the fidelity of the synaptic response ([@bib24]).

Here we present an alternative mechanism that can account for autoinactivation without requiring changes in AMPAR-TARP interactions. We examined the effect of TARP γ-2 on the occupancy dependence of AMPAR gating and the concentration dependence of AMPAR desensitization. We show that γ-2 enhances the efficacy of glutamate by facilitating the opening of singly occupied receptors. Furthermore, we find that γ-2 reduces the sensitivity of GluA1 to desensitization by low concentrations of glutamate, slowing desensitization across all concentrations of glutamate. A kinetic model incorporating these dual effects of TARPs on glutamate efficacy that fully replicates our data suggests that TARPs amplify the transduction of spillover-mediated synaptic signaling and offers an alternative explanation for AMPAR autoinactivation with no requirement for desensitization-induced physical or functional uncoupling of the auxiliary subunits.

Results {#sec2}
=======

TARP γ-2 Reduces Desensitization of AMPARs by Low Concentrations of Glutamate {#sec2.1}
-----------------------------------------------------------------------------

TARPs increase the potency of glutamate to activate AMPARs ([@bib65], [@bib69]), but their effects on the potency of glutamate to promote AMPAR desensitization have not been established. To address this, we recorded currents evoked by fast application of glutamate to outside-out patches from HEK293 cells transfected with GluA1 alone or with GluA1 plus γ-2 (GluA1/γ-2). From measuring peak current amplitudes we found, as expected, that γ-2 enhanced glutamate potency ([Figures 1](#fig1){ref-type="fig"}A and 1C). By contrast, there was a marked decrease in the ability of a pre-applied low concentration of glutamate to induce AMPAR desensitization ("pre-desensitization") and reduce peak currents ([Figures 1](#fig1){ref-type="fig"}B and 1C). Thus, although γ-2 produced an ∼4-fold decrease in the glutamate concentration required for half-maximal peak current (*EC*~50,\ Pk~) (from 1.2 ± 0.2 to 0.27 ± 0.03 mM, n = 6 and 7, p = 0.0017), the concentration of pre-applied glutamate required for half-maximal inhibition (*IC*~50~) was increased 5-fold (from 0.48 ± 0.1 to 2.6 ± 0.3 μM, n = 7 and 8, p = 0.00019) ([Figure 1](#fig1){ref-type="fig"}D).Figure 1γ-2 Has Opposite Effects on Glutamate Potency for Activation and Desensitization(A) Representative currents (--60 mV) elicited by fast applications of glutamate to outside-out patches from HEK293 cells transfected with GluA1 (left) or GluA1/γ-2 (right).(B) Currents elicited by 10 mM glutamate following pre-desensitization by a range of lower glutamate concentrations.(C) Pooled data fit with the Hill equation showing opposite γ-2-induced shifts in GluA1 potency for activation (filled circles) and desensitization (open circles). Symbols indicate mean and error bars indicate SEM.(D) Pooled data showing glutamate *EC*~50~ for peak currents and glutamate *IC*~50~ for pre-exposure. Bars show mean and error bars show SEM.(E) Representative GluA1/γ-2 currents. Inset: peak and steady-state concentration-response curves from the illustrated records. Note the inflection in the steady-state curve.(F) Pooled data (n = 6 patches). Peak currents were well described by a single Hill function, and steady-state currents were best described by a double Hill function. Error bars denote SEM. ^∗∗^p \< 0.01, ^∗∗∗^p \< 0.001 (Welch t test).See also [Figure S1](#mmc1){ref-type="supplementary-material"}.

Steady-State Concentration-Response Relationships {#sec2.2}
-------------------------------------------------

Unlike cells transfected with GluA1 alone, where steady-state currents were too small to analyze, those transfected with GluA1 and γ-2 exhibited appreciable steady-state currents ([Figure 1](#fig1){ref-type="fig"}E). In all patches examined, the steady-state concentration-response relationships were biphasic, whereas the corresponding peak current relationships were sigmoidal ([Figure 1](#fig1){ref-type="fig"}F). Specifically, the steady-state relationships demonstrated a clear inflection at intermediate concentrations of glutamate, either at 100 μM (two of six patches) or 300 μM (four of six patches), producing a "shoulder" in the pooled concentration-response curve ([Figure 1](#fig1){ref-type="fig"}F; [Figure S1](#mmc1){ref-type="supplementary-material"}).

Biphasic steady-state concentration-response curves, including bell-shaped curves with a clear peak at submaximal concentrations of glutamate, followed by a progressive decline at higher concentrations, have been reported previously for both native ([@bib48]) and TARPed recombinant AMPARs ([@bib40], [@bib55]). This behavior has been termed autoinactivation and ascribed to a functional uncoupling of the AMPAR/TARP complex following desensitization-induced partial or complete dissociation of TARPs from AMPARs, although this interpretation remains controversial ([@bib40], [@bib55]). The biphasic steady-state concentration-response relationship we measured could conceivably be interpreted as reflecting the presence of a mixture of TARPed and TARPless receptors rather than autoinactivation. However, this is unlikely because the peak concentration-response curve showed no evidence of a similar biphasic relationship.

Evidence for Maintained AMPAR/TARP Association {#sec2.3}
----------------------------------------------

If desensitization were to induce functional uncoupling of the AMPAR/TARP complex, one might predict that this would lead to changes in multiple TARP-dependent AMPAR properties. To test this, we examined two such properties for both peak and steady-state currents---the voltage-dependent block by intracellular spermine ([@bib61]) and the mean channel conductance ([@bib62], [@bib69]; [Experimental Procedures](#sec4){ref-type="sec"}). At steady state, both polyamine block (as judged by voltage of half-maximal block) and channel conductance (estimated from fluctuation analysis) were comparable with values obtained at peak ([Figures 2](#fig2){ref-type="fig"}A--2F). This result suggests that a majority of the steady-state current is mediated by AMPARs that remain functionally coupled to TARPs. However, although these experiments found no evidence for functional uncoupling, they do not refute its existence. The higher steady-state open probability of TARPed AMPARs would mean that they could contribute a majority of the equilibrium current even when they represented a minority of the receptor population.Figure 2Measures of Conductance, Polyamine Block, and Kainate Efficacy Suggest Maintained AMPAR/TARP Association following Desensitization(A) Representative GluA1/γ-2 *I-V* data. Peak and steady-state currents are scaled between 0 and --60mV.(B) Conductance-voltage (*G-V*) plots of peak (GluA1 with- and without γ-2) and steady-state responses (GluA1/γ-2 only). Symbols indicate mean and error bars indicate SEM. Dashed lines are fits of the Boltzmann equation ([Supplemental Experimental Procedures](#mmc1){ref-type="supplementary-material"}), from which values of voltage of half-maximal block (*V*~1/2~) were determined. The steady-state current of GluA1 alone was too small to analyze.(C) Pooled data showing *V*~1/2~ of spermine block (one-way ANOVA, *F*~2,\ 8.7~ = 311.53, p \< 0.0001). Bars indicate mean and error bars indicate SEM.(D) Representative averaged glutamate-activated GluA1/γ-2 current (82 applications). Non-stationary fluctuation analysis (NSFA) was applied to the first 95% of the decay (inset, gray shading) and compared with stationary fluctuation analysis (SFA) of steady-state currents (red shading).(E) Representative current variance plots for the decaying component (NSFA, filled symbols) and steady-state component (SFA, open symbol), yielding the indicated channel conductance estimates.(F) Pooled data showing weighted mean channel conductance (one-way ANOVA, *F*~2,\ 18.9~ = 14.51, p = 0.00015). Bars indicate mean and error bars indicate SEM.(G and H) Representative traces (G) and scaled responses (H) showing 10 mM glutamate- and 1 mM kainate-evoked currents as GluA1/γ-2 recovers from desensitization induced by 10 mM glutamate.(I) Pooled data from four to five patches showing that the time course of recovery is the same for both agonists. ^∗∗^p \< 0.01, ^∗∗∗^p \< 0.001 (Welch t test).

We next searched for evidence of functional uncoupling under non-steady-state conditions using a different marker of TARP association---the enhanced efficacy of kainate at TARP-associated AMPARs ([@bib69]). It has been proposed that, following desensitization-induced functional uncoupling, the recovery of receptors from desensitization precedes TARP re-association ([@bib40]). If this is indeed the case, then the glutamate-evoked peak current (a measure of all non-desensitized receptors) should recover from desensitization more quickly than the kainate-evoked current (an indicator of TARP-associated non-desensitized receptors). However, following desensitization of GluA1/γ-2 by 10 mM glutamate, the recovery of both glutamate- and kainate-evoked currents displayed broadly similar kinetics (time constant of recovery of glutamate-evoked currents \[τ~Glu~\] = 150 ± 20 ms, time constant of recovery of kainate-evoked currents \[τ~KA~\] = 150 ± 10 ms, n = 5 and 4, p = 0.99; [Figures 2](#fig2){ref-type="fig"}G--2I).

Alternative Origins of Autoinactivation {#sec2.4}
---------------------------------------

In the absence of firm evidence to support functional uncoupling of TARPs from AMPARs, we next asked how else TARP-coupled receptors could generate biphasic steady-state concentration-response curves. AMPAR desensitization is known to result from rupture of the interface between LBD dimers following agonist binding ([@bib2], [@bib38], [@bib64]). Indeed, in the absence of TARPs, there is compelling evidence that this can be triggered by the glutamate occupation of a single LBD ([@bib50]). It has been proposed that TARPs stabilize LBD dimers, slowing desensitization ([@bib47]), possibly mediated by interactions between the lower lobe of the LBD and the first extracellular loop of the TARP ([@bib7], [@bib14], [@bib35], [@bib36], [@bib56], [@bib73], [@bib78]). We speculated that such γ-2-mediated stabilization might prevent efficient initiation of desensitization when only a single LBD is bound by glutamate, thereby enhancing occupancy dependence of the desensitization rate. Indeed, the decreased ability of pre-applied (low-concentration) glutamate to induce pre-desensitization of GluA1/γ-2 might be anticipated if desensitization became a co-operative process in the presence of γ-2, with singly occupied dimers desensitizing much more slowly than those that are doubly occupied.

We modeled this principle using a simple kinetic scheme with two agonist-dependent open, closed, and desensitized states ([Figure 3](#fig3){ref-type="fig"}A, scheme 1). Using rate constants from a previously proposed model of GluA1 ([@bib50]), both peak and steady-state concentration-response curves were sigmoidal ([Figure 3](#fig3){ref-type="fig"}B). However, when we restricted the desensitization of singly occupied receptors, either by reducing the desensitization rates or increasing recovery rates, the steady-state concentration-response became bell-shaped ([Figure 3](#fig3){ref-type="fig"}C).Figure 3A Basic Kinetic Scheme Can Predict Biphasic Steady-State Concentration-Response Relationships(A) A simple model, scheme 1, with two agonist binding steps (R0 → R1→ R2), two desensitized states (D1 and D2), and two open states (O1 and O2) with an equal conductance.(B) Using rates based on previously published values for GluA1 ([@bib50]; *k*~on~ = 2 × 10^7^ M^−1^s^−1^, *k*~off~ = 9,000 s^−1^, α~1~ = α~2~ = 3,100 s^−1^, β~1~ = β~2~ = 8,000 s^−1^, δ~1~ = δ~2~ = 1,800 s^−1^, γ~1~ = γ~2~ = 35 s^−1^), scheme 1 generates sigmoidal concentration response curves for both peak and steady-state activation.(C) Decreasing occupancy of D1 relative to D2 (for example, increasing γ~1~ or δ~2~) or increasing the occupancy of O1 relative to O2 (for example, increasing α~2~ or β~1~) leads to biphasic steady-state concentration-response curves with minimal effects on peak concentration-response curves.

γ-2 Influences the Concentration Dependence of Desensitization and Recovery {#sec2.5}
---------------------------------------------------------------------------

To better understand the influence of TARPs on AMPAR desensitization and to determine whether the receptors did indeed display concentration-dependent properties that could account for autoinactivation, we next examined the effect of γ-2 on the onset of GluA1 desensitization over a range of glutamate concentrations. For concentrations of glutamate ≥10 μM, we determined the kinetics of desensitization by directly fitting current decays ([Figure 4](#fig4){ref-type="fig"}A), whereas, for concentrations \<10 μM, we measured the time course of peak current inhibition following glutamate pre-incubation ([Figure 4](#fig4){ref-type="fig"}B). The rate of onset of desensitization appeared to be independent of glutamate concentration above 300 μM, both for receptors with and without γ-2. However, it slowed markedly at concentrations below 100 μM ([Figure 4](#fig4){ref-type="fig"}C), and, unlike GluA1, GluA1/γ-2 desensitization was barely detectable at glutamate concentrations below 1 μM.Figure 4Concentration Dependence of GluA1/γ-2 Entry into and Exit from Desensitized States(A) Representative normalized GluA1/γ-2 currents (--60 mV) showing markedly slowed desensitization at low glutamate concentrations (time constant of desensitization \[τ~des~\] is 2.8 ms with 10 mM glutamate and 8.9 ms with 30 μM).(B) Representative records showing the time course of entry into desensitization (jumping between control, 10 μM glutamate, and 10 mM glutamate). Three selected pulse protocols are illustrated. The dashed line is an exponential fit, giving a time constant of 26.6 ms.(C) GluA1 (blue) and GluA1/γ-2 (black) desensitization kinetics measured using protocols of the type shown in (A) or (B) (n = 5--8; filled or open symbols, respectively). Symbols indicate mean and error bars indicate SEM.(D) Recovery from desensitization by 10 μM glutamate measured using a two-pulse protocol. Three selected pulse protocols are illustrated. The dashed line is an exponential fit, giving a time constant of 119 ms.(E) Monoexponential Hodgkin-Huxley fits of pooled averaged time courses of GluA1 recovery from desensitization by 10 μM, 100 μM, or 10 mM glutamate (n = 7). Recovery profiles are fitted with a single time constant (120 ms) with a variable *m* ([Experimental Procedures](#sec4){ref-type="sec"}).(F) GluA1/γ-2 recovery from desensitization by a range of glutamate concentrations. Data were globally fitted with a double exponential function, giving fast time constant of recovery (τ~f~) = 74 ms and slow time constant of recovery (τ~s~) = 390 ms. Inset: the kinetics of recovery from desensitization; the weighted time constant of recovery (τ~w~) is not markedly concentration-dependent.

We also examined the effect of γ-2 on recovery from desensitization ([Figures 4](#fig4){ref-type="fig"}D--4F). The recovery of TARPless AMPARs from desensitization has been shown previously to exhibit a delay that can be fitted using Hodgkin-Huxley kinetics, where an exponent "*m*" \> 1 indicates the occurrence of multiple, concurrent, kinetically similar rate-limiting steps ([@bib50]). Consistent with this, our mean GluA1 recovery time course could be described by a monoexponential Hodgkin-Huxley (H-H) fit ([Figure 4](#fig4){ref-type="fig"}E). In the presence of γ-2, the recovery did not show a lag, and data were fitted with a simple double exponential ([Figure 4](#fig4){ref-type="fig"}F). Thus, for receptors containing γ-2, recovery from desensitization does not involve the same rate-limiting steps seen with receptors that lack γ-2. Of note, we found very limited concentration dependence of the recovery from desensitization ([Figure 4](#fig4){ref-type="fig"}F, inset). Taken together, these data show that GluA1/γ-2 displays a marked concentration dependence of entry into, but not recovery from, desensitization. As shown in [Figure 2](#fig2){ref-type="fig"}, such a decreased desensitization rate at low receptor occupancy is predicted to result in autoinactivation.

Glutamate Efficacy at Low Occupancy Is Increased by γ-2 {#sec2.6}
-------------------------------------------------------

To further assess glutamate efficacy at partially occupied receptors, we recorded glutamate-activated currents following pre-incubation with a competitive antagonist ([@bib12], [@bib51]). Although the binding of glutamate and the gating of AMPARs is fast (current rise times, ∼200 μs), the unbinding of competitive antagonists such as 2,3-dioxo-6-nitro-1,2,3,4-tetrahydrobenzo\[f\]quinoxaline-7-sulfonamide (NBQX) is several orders of magnitude slower ([@bib36]). Thus, by saturating receptors with NBQX before fast application of glutamate, the time course and process of channel activation can be directly observed as NBQX molecules slowly unbind and are replaced by glutamate over a period of hundreds of milliseconds ([Figure 5](#fig5){ref-type="fig"}A).Figure 5γ-2 Increases the Efficacy of Glutamate at Partially Liganded AMPARs(A) Schematic of slow NBQX unbinding, which allows the time course of channel activation by glutamate to be observed.(B) Normalized representative currents recorded following 50 μM NBQX/10 mM glutamate exchange (with 50 μM cyclothiazide). γ-2 speeds the current onset (enlargement of the highlighted section), reducing the Hodgkin-Huxley exponent (*m*) required to fit the records (dashed red lines).(C) Pooled data from H-H fits. γ-2 accelerated the onset of NBQX/glutamate currents for each AMPAR subtype. Two-way ANOVA indicated significant main effects for AMPAR type (*F*~2,\ 31~ = 48.43, p \< 0.0001) and for γ-2 (*F*~1,\ 31~ = 187.97, p \< 0.0001) but no interaction between AMPAR type and TARP (*F*~2,\ 31~ = 0.41, p = 0.67). ^∗∗^p \< 0.01, ^∗∗∗^p \< 0.001 (Welch t test). Symbols indicate mean and error bars indicate SEM.(D) Representative single-channel NBQX/glutamate records displaying four discrete conductance levels. Measured conductance values are indicated.(E) Normalized probability densities for closed, O1, O2, O3, and O4 conductance states, pooled from 560 identified conductances in 134 NBQX/glutamate sweeps. The dashed red lies are Gaussian fits.(F) Normalized, pooled GluA1/γ-2 NBQX/glutamate current (n = 6). Data are fit (dashed red line) using the scheme shown in (A) (*k*~NBQX~, 19 s^--1^), with the mean estimates of the four conductance states (O1, 3.7 pS; O2, 16.1 pS; O3, 30.6 pS; O4, 38.6 pS).See also [Figure S2](#mmc1){ref-type="supplementary-material"}.

Patches from cells expressing GluA1 or GluA1/γ-2 were initially exposed to 50 μM NBQX, followed by a rapid switch to 10 mM glutamate, all in the presence of cyclothiazide to prevent desensitization. We found that this "NBQX/glutamate" protocol resulted in macroscopic currents that displayed sigmoidal kinetics ([Figure 5](#fig5){ref-type="fig"}B), as previously reported for AMPAR-mediated currents evoked in patches from cultured hippocampal neurons in response to an analogous CNQX/kainate protocol ([@bib12]). The observed delay in current onset is consistent with multiple agonist binding events being necessary to activate AMPARs ([@bib50], [@bib51]). To describe the rising phase of the responses, we fitted the currents with a mono-exponential Hodgkin-Huxley function ([Experimental Procedures](#sec4){ref-type="sec"}). For GluA1 alone, the currents could be described with a Hodgkin-Huxley exponent of 2.4 ± 0.1 (n = 6) ([Figures 5](#fig5){ref-type="fig"}B and 5C). This value suggests that more than two sequential binding events are necessary for full channel opening. On co-expression of γ-2, the required exponent was reduced to 1.4 ± 0.05 (n = 6, p \< 0.0001), suggesting that fewer agonist binding events are necessary to gate AMPARs in the presence of TARPs ([Figure 5](#fig5){ref-type="fig"}C). A similar effect of γ-2 was seen when co-expressed with GluA2(Q) homomers or GluA1/2(R) heteromers ([Figure 5](#fig5){ref-type="fig"}C) and with the tandem construct GluA1_γ-2 (data not shown). Thus, association with γ-2 not only reduces desensitization but also substantially lowers the barrier to channel opening, resulting in enhanced gating of partially occupied AMPARs.

In four patches from cells expressing GluA1_γ-2 or GluA2(Q)/γ-2, where only a single channel was active and the background noise was sufficiently low, we were able to analyze in detail the subconductance levels. This allowed us to assign conductance values to the different states of occupancy ([Figure 5](#fig5){ref-type="fig"}D). Unlike TARPless receptors, which show three conductance steps in response to fast glutamate application following pre-incubation with NBQX ([@bib51]), with the TARPed receptors, we could resolve up to four sequential openings of increasing conductance (O1, O2, O3, and O4). Based on their position within the "staircase-like" sequence, we identified O4 in 100% of 134 sweeps, O3 in 93%, O2 in 83%, and O1 in 42%. That we were unable to identify O1 in all sweeps is to be expected, given that O1 has the lowest conductance, is the shortest-lived state, and can be identified unambiguously only when all three other states are resolved. The final weighted all-point amplitude histograms ([Experimental Procedures](#sec4){ref-type="sec"}) yielded conductances for O1--O4 of 3.7, 16.1, 30.6, and 38.6 picosiemens (pS) ([Figure 5](#fig5){ref-type="fig"}E). Incorporating these four conductance values into the NBQX-unbinding scheme ([Figure 5](#fig5){ref-type="fig"}A) provided an excellent fit to the macroscopic NBQX/glutamate responses ([Figure 5](#fig5){ref-type="fig"}F). Of note, for macroscopic currents from GluA1/2(R)/γ-2 heteromers, the Hodgkin-Huxley exponent (*m*) was less than that of homomeric receptors ([Figure 5](#fig5){ref-type="fig"}C). We performed simulations ([Figure S2](#mmc1){ref-type="supplementary-material"}) that revealed that a reduced value of *m* can be indicative of an increased relative conductance of state O1. Thus, for the four states of GluA1/γ-2 (3.7, 16.1, 30.6, and 38.6 pS), the simulation yields an *m* of 1.38. However, if each state displays a conductance proportional to its occupancy (for example 5, 10, 15, and 20 pS), then *m* is precisely 1. Further, if the relative contribution of O1 is increased, then *m* can even be less than 1 ([Figure S2](#mmc1){ref-type="supplementary-material"}). Although directly discerning modest differences in single-channel conductance states is not technically feasible for GluA1/2(R) heteromers (because of their low conductance), our macroscopic data suggest that O1 may make a greater contribution to currents from heteromeric GluA1/2(R) receptors than from homomeric GluA2(Q).

Kinetic Modeling of GluA1/γ-2 {#sec2.7}
-----------------------------

We next attempted to mimic our data by modifying the full kinetic scheme previously developed for GluA1 (scheme RH, [Figure S3](#mmc1){ref-type="supplementary-material"}A; [@bib50]). Using this scheme, and allowing the published rates to vary by ≤20%, we were able to replicate our GluA1 concentration-response curves for peak activation and desensitization as well as the observed kinetics of desensitization and recovery ([Figures S3](#mmc1){ref-type="supplementary-material"}B--S3D).

To accommodate our GluA1/γ-2 data, we modified scheme RH. To reflect the TARP-dependent reduction in desensitization by low concentrations of glutamate, we decreased the rate of desensitization of mono-liganded TARPed receptors (R1 → D1). We also included an additional open state, O1, and assigned O1--O4 the measured subconductances from [Figure 5](#fig5){ref-type="fig"}. Finally, for improved estimation of our steady-state dose-response curves, we assigned doubly and triply liganded receptors equal opening rates. With these changes, our modified scheme (scheme 2, [Figure 6](#fig6){ref-type="fig"}A) was able to approximate all three concentration-response relationships, notably reducing the separation between desensitization sensitivity and channel activation, and replicating the shoulder of the steady-state data ([Figure 6](#fig6){ref-type="fig"}B). The same set of rate constants was also able to describe the kinetics of desensitization ([Figure 6](#fig6){ref-type="fig"}C) and recovery ([Figure 6](#fig6){ref-type="fig"}D) at multiple glutamate concentrations. Of note, modest changes to rate constants in our model were able to generate bell-shaped steady-state concentration-response curves ([@bib40], [@bib55]; data not shown). Overall, scheme 2 is capable of accommodating and explaining key functional properties of GluA1/γ-2, including the biphasic concentration-response curves previously suggested to arise from the functional uncoupling of TARPs and AMPARs.Figure 6A Revised Kinetic Scheme Can Approximate Multiple Aspects of GluA1/γ-2 Behavior(A) Scheme 2 is a modified form of scheme RH, with mechanistic changes highlighted (red) and assigned conductance levels (green).(B--D) A single set of rates within scheme 2 can simultaneously approximate (dashed red lines) the three concentration response relationships (B), desensitization kinetics (C), and recovery kinetics (D) of GluA1/γ-2. Symbols indicate mean and error bars indicate SEM. The following rate constants were used: *k*~1~ = 1.3 × 10^7^ M^--1^s^--1^, *k*~*--*1~ = 3,000 s^--1^, α = 1,000 s^--1^, β = 6,000 s^--1^, δ~1~ = 1,200 s^--1^, γ~1~ = 16 s^--1^, δ~2~ = 1,300 s^--1^, γ~2~ = 3,900 s^--1^, δ~3~ = 250 s^--1^, δ~0~ = 0.48 s^--1^, γ~0~ = 4.4 s^--1^, *k*~--2~ = 63 s^--1^, and *k*~--3~ = 630 s^--1^.See also [Figure S3](#mmc1){ref-type="supplementary-material"}.

Modeling of Synaptic Currents {#sec2.8}
-----------------------------

It seemed likely that the behavior we observed for GluA1/γ-2 at low glutamate concentrations would be expected to result in a decreased desensitization of synaptic receptors by prolonged low concentrations of transmitter of the sort that can occur during spillover ([@bib9], [@bib16], [@bib43]) or delayed synaptic clearance ([@bib71]). Using either scheme RH (for GluA1) or scheme 2 (for GluA1/γ-2), we simulated brief receptor activations (two 1-ms pulses, 10 mM glutamate, 10-ms interval) with or without the continued presence of 1 μM glutamate. Scheme RH predicted that this concentration of background glutamate would inhibit GluA1-mediated charge transfer by 66%. By contrast, scheme 2 predicted only an 18% reduction in GluA1/γ-2-mediated charge transfer. These predictions were borne out by experiments in which 1 μM glutamate resulted in a 56% ± 3% inhibition of GluA1 (n = 4) but only 14% ± 5% inhibition of GluA1/γ-2 (n = 5, p = 0.00039) ([Figures 7](#fig7){ref-type="fig"}A--7C).Figure 7Co-expression of γ-2 Reduces Inhibition of GluA1-Mediated Charge Transfer by Background Glutamate and Is Predicted to Enhance Charge Transfer by Spillover(A) Simulated responses of GluA1 (scheme RH, left) and recorded GluA1 currents (right) in response to two 1-ms pulses of 10 mM glutamate (100 Hz), with and without background application of 1 μM glutamate. Charge transfer was measured as the area under the curve.(B) As for (A) but for GluA1/γ-2, simulated using scheme 2, and for GluA1/γ-2 currents.(C) Bar chart showing that simulations and data are in agreement, with ∼4-fold less glutamate-mediated reduction in charge transfer for γ-2-containing receptors than for GluA1 alone. Bars indicate mean and error bars indicate SEM.(D and E) Responses of GluA1 (scheme RH) and GluA1/γ-2 (scheme 2) to simulated synaptic glutamate waveforms ([@bib43]). The concentration profiles used represent (D) fusion of a single vesicle either locally or at the nearest-neighbor active zone or (E) action potential-evoked release causing prolonged spillover, either with or without local release. Spillover or nearest-neighbor charge as a percentage of direct or local charge is indicated. ^∗∗∗^p \> 0.001 (Welch t test).See also [Figure S4](#mmc1){ref-type="supplementary-material"}.

Having demonstrated that γ-2 reduces the inhibitory effects of background glutamate on GluA1 charge transfer and that scheme 2 is capable of replicating these properties, we next used scheme RH and scheme 2 to model GluA1 and GluA1/γ-2 responses to glutamate spillover waveforms. To this end, as an exemplar, we used a previously developed diffusion model of the cerebellar mossy fiber to granule cell (MF-GC) synapse ([@bib43]), allowing us to model AMPAR activation by local vesicular release or spillover from distant release sites ([@bib16]). We first modeled the influence of γ-2 on responses to single-vesicle fusion events ([Figure 7](#fig7){ref-type="fig"}D). As expected, the peak channel conductance following local release was increased by γ-2, and the total charge transfer (measured over 3 ms) was ∼5-fold larger than that modeled with GluA1 alone. However, when we simulated the response to vesicle fusion at the nearest neighboring synapse, charge transfer was increased \>20-fold by γ-2. Indeed, for GluA1/γ-2, the total predicted charge transfer from nearest-neighbor release was over half of that elicited by local release.

We next simulated GluA1 and GluA1/γ-2 responses to evoked release. The MF-GC synaptic model consists of a 7 × 7 array of synaptic connections, with the central synapse being monitored, and, following an action potential, the probability of vesicular release at any one site is 0.46 ([@bib43]). We simulated two glutamate waveforms: with the presence of local release (direct + spillover) and in the absence of local release (spillover only). Again, γ-2 greatly influenced the predicted response, increasing total charge transfer by \>5-fold for direct activation but by 12-fold for spillover only. In this case, GluA1/γ-2 spillover-mediated charge transfer was predicted to reach nearly 70% of that resulting from direct activation. For both local and evoked release, increased charge transfer in the presence of γ-2 is to be expected, given the known action of TARPs on AMPAR conductance and deactivation. The dual effects of TARPs on the desensitization and conductance of singly occupied AMPARs make only a limited contribution to the increase in charge following direct release (\<10%), but they contribute ∼40% of charge transfer for evoked spillover currents and ∼65% of charge transfer from nearest-neighbor single-vesicle release ([Figure S4](#mmc1){ref-type="supplementary-material"}). Accordingly, our findings suggest that the behavior of synaptic receptors during glutamate spillover will be profoundly influenced by the presence of TARPs.

Discussion {#sec3}
==========

One of the canonical properties of TARPs is their ability to reduce AMPAR desensitization ([@bib47], [@bib69], [@bib72]). Surprisingly, despite the importance of desensitization during spillover and delayed clearance of transmitter following an excitatory postsynaptic current (EPSC) ([@bib17], [@bib71]), the influence of TARPs on AMPAR desensitization at low concentrations of glutamate has not been described previously. By determining the glutamate concentration dependence of TARP action, we have revealed three fundamental features of AMPAR behavior. First, we find that γ-2 induces opposite shifts in glutamate potency for AMPAR desensitization (∼5-fold increase in *IC*~50~) and activation (∼4-fold reduction in *EC*~50~). Second, for γ-2-containing receptors, we find a marked concentration dependence of entry into, but not recovery from, desensitization, revealing a TARP-induced increase in the steady-state efficacy of low concentrations of glutamate. Third, we find that γ-2 also enhances the efficacy of glutamate by promoting the opening of singly occupied receptors. Together, our data indicate that γ-2 shifts the balance of GluA1 gating at low agonist concentrations from desensitization to activation. Our experiments and simulations suggest that this altered AMPAR gating, rather than a functional uncoupling of TARPs, is likely to account for the phenomenon of autoinactivation. Moreover, we propose that this TARP-dependent behavior at low glutamate concentrations will greatly enhance the response of AMPARs during transmitter spillover.

Using the kinetic scheme of [@bib50], we were able to replicate our concentration response and kinetic data by introducing an open state for the singly occupied receptor, slowing its rate of entry into the desensitized state (R1 → D1), and incorporating the occupancy-dependent conductance values from our single-channel patches. However, this scheme does not generate "superactivation," a slow "run-up" of AMPAR/TARP currents on a timescale of ∼1 s ([@bib8]). As with autoinactivation, superactivation has been proposed to result from a state dependence of the functional interaction between AMPAR and TARP. This is potentially reflected in single-channel records as a high open probability "mode" ([@bib77]) that contributes to "steady-state" currents seen during trains of glutamate application ([@bib15]). We did not observe superactivation in our recordings, perhaps because the phenomenon appears to be less pronounced for γ-2 than for other TARPs ([@bib28]) and is most evident when AMPARs are saturated with TARPs ([@bib8]).

Our model accommodates all of our experimental data and suggests an alternative explanation for the phenomenon of autoinactivation that does not require functional uncoupling of AMPAR and TARP. Of note, markedly biphasic steady-state concentration-response curves are characteristic of kainate receptors (KARs), fellow members of the ionotropic glutamate receptor (iGluR) superfamily, and occur independent of auxiliary subunits. For heteromeric KARs containing low-affinity (GluK1--3) and high-affinity (GluK4--5) subunits, only the high-affinity subunit of each LBD dimer is occupied at low glutamate concentrations, and this is sufficient to cause channel openings of maximal conductance ([@bib41], [@bib59]) but not receptor desensitization ([@bib20], [@bib41]). Only at high glutamate concentrations, when the low-affinity subunit is also occupied, can desensitization be triggered. Although the full gating and minimal desensitization at low occupancy are more pronounced for KARs, we propose that TARPed AMPARs behave in a comparable manner.

Using three different approaches we found no evidence for AMPAR/TARP uncoupling. However, we cannot exclude that desensitized AMPARs (for example, those in state D4) are functionally or physically uncoupled from TARPs but then rapidly re-associate (in state R4). Nevertheless, biochemical evidence supporting the concept of functional uncoupling---AMPAR agonist-triggered reduction in AMPAR and TARP co-immunoprecipitation ([@bib40], [@bib68])---was not observed in other studies ([@bib42], [@bib55]). Further, although three different AMPAR_TARP tandem constructs were originally shown not to autoinactivate ([@bib40]), a subsequent study observed autoinactivation of the GluA4_γ-2 tandem, suggesting that this phenomenon can occur in the absence of physical dissociation ([@bib55]).

Recent cryoelectron microscopy (cryo-EM) structures of GluA2/γ-2 reveal extensive intra-membrane contacts between AMPAR and TARP ([@bib73], [@bib78]), and these appear to be important both for AMPAR/TARP assembly and function ([@bib4]). Although the cryo-EM structures are of channels in their closed states, the conformation of AMPAR transmembrane regions are predicted to be similar following desensitization ([@bib18], [@bib19], [@bib38], [@bib60]). Therefore, one might expect that, in the desensitized state, TARPs maintain a close association with the AMPAR. By contrast, the AMPAR extracellular domains undergo large rotational rearrangements following desensitization ([@bib19], [@bib26], [@bib38]), which would be expected to break the charge-mediated interactions between the AMPAR LBD and TARP Ex1 ([@bib14], [@bib73], [@bib78]) in at least one subunit. Even so, although alteration of the charges in the LBD has been shown to greatly diminish TARP-induced slowing of deactivation and desensitization, other TARP-associated effects persisted (increased kainate efficacy and decreased block by intracellular spermine) ([@bib14]), suggesting that, even when LBD/Ex1 interaction is eliminated, TARPs and AMPARs remain functionally coupled.

Our results suggest that the dual effects of TARPs on glutamate efficacy will have the greatest effect on native receptors during prolonged exposure to low concentrations of glutamate, as occurs, for example, during transmitter spillover ([@bib9], [@bib16], [@bib17], [@bib43]), delayed synaptic clearance ([@bib32], [@bib44], [@bib71], [@bib75]), or volume transmission ([@bib66]). Specifically, TARP-associated AMPARs will be able to pass appreciable current when exposed to low-micromolar glutamate and will remain responsive to high concentrations of glutamate resulting from vesicular release. Our synaptic simulations demonstrate that γ-2 imparts a marked resistance to desensitization by glutamate spillover and allows significant postsynaptic responses even in the absence of local release. Generalizing this action of γ-2 to the GluA2/4 heteromers present in cerebellar granule cells would account for the large steady-state currents generated by synaptic AMPARs in these cells ([@bib17]). Activation of AMPARs via glutamate spillover accounts for the majority of the charge injected into granule cells during high-frequency mossy fiber stimulation ([@bib52]) and underlies the primary excitatory drive of granule cells during locomotion ([@bib46]). Thus, resistance to desensitization of TARP-associated AMPARs appears to be key for synaptic signaling in the input layer of the cerebellum and is likely important at other sites where glutamate spillover occurs.

Experimental Procedures {#sec4}
=======================

Heterologous Expression {#sec4.1}
-----------------------

HEK293 cells were transfected with recombinant AMPAR subunits and TARPs (plus EGFP). AMPAR subunit cDNAs (rat) were "flip" splice variants, and the GluA2 forms were additionally arginine/glycine (R/G)-edited. The GluA1_γ-2 tandem consisted of full-length GluA1 and a nine-amino acid linker (GGGGGEFAT) before the start codon of full-length γ-2. For further details, see the [Supplemental Experimental Procedures](#mmc1){ref-type="supplementary-material"}.

Rapid Agonist Application to Excised Patches {#sec4.2}
--------------------------------------------

Voltage-clamp recordings were made from outside-out patches. Rapid agonist application was achieved by switching between continuously flowing solutions using piezoelectric translation of an application tool made from either theta glass or custom triple-barreled glass, as described in the [Supplemental Experimental Procedures](#mmc1){ref-type="supplementary-material"}.

Data Analysis and Kinetic Modeling {#sec4.3}
----------------------------------

Records were analyzed using Igor Pro 6.35 (Wavemetrics) with Neuromatic 2.8 (<http://www.neuromatic.thinkrandom.com>). Kinetic simulations were performed in Scilab 5.5.0. (Scilab Enterprises; <http://www.scilab.org>). For further details, see the [Supplemental Experimental Procedures](#mmc1){ref-type="supplementary-material"}.

Data Presentation and Statistical Analysis {#sec4.4}
------------------------------------------

Summary data are presented in the text as mean ± SEM (from *n* patches). Comparisons involving two datasets only were performed using a two-sided Welch two-sample t test that did not assume equal variance (normality was not tested statistically but gauged from quantile-quantile \[Q-Q\] plots and/or density histograms). Analyses involving data from three or more groups were performed using one- or two-way ANOVA (Welch heteroscedastic *F* test), followed by pairwise comparisons using two-sided Welch two-sample t tests with Bonferroni correction where appropriate. Differences were considered significant at p \< 0.05. Exact *p* values are presented to two significant figures, except when p \< 0.0001. Differences were considered significant at p \< 0.05. Statistical tests were performed using R (3.3.2, the R Foundation for Statistical Computing; <http://www.r-project.org/>) and R Studio (1.0.143, RStudio). No statistical test was used to predetermine sample sizes; these were based on standards of the field. No randomization was used.
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